therapeutic claims are not supported by FDA approval
Where to Buy Survodutide: Price & Vendor Guide BI 456906 dual agonist pricing, why 10mg vials are the norm, and what a real 4,610 Da COA proves
Latest Wegovy Lawsuit Updates July 1, 2026: More GLP-1 Lawsuits Filed Into MDLs Growth continues for the GLP-1 lawsuits involving drugs like Wegovy
There is no TGA-registered BPC-157 product for therapeutic use in Australia, and as of June 2024 BPC-157 is a Schedule 4 (prescription-only) substance, meaning any legal supply must come through a doctors prescription via a compounding pharmacy
DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy
The FDA has also shared safety information on compounded and counterfeit "semaglutide" on their website here, with the most recent counterfeit report here (April 2025)